Skip to main content
Premium Trial:

Request an Annual Quote

Protein Design Labs to Use Cyntellect s LEAP Platform

NEW YORK, Oct. 27 (GenomeWeb News) - Protein Design Labs will use Cyntellect's Cell Xpress Laser Enabled Analysis and Processing service, the companies said yesterday.

 

Cyntellect's LEAP platform, which is part of the company's Cell Xpress service, was designed to enable researchers to image and measure protein secretions in situ in high-throughput on individual cells.

 

Financial terms of the deal were not disclosed.

 

The news comes one month after Cyntellect received around $1.5 million in a Phase II Small Business Innovative Research grant to continue developing RNA interference applications on the LEAP platform.

 

Specifically, the money will help the privately held company develop its LEAP-enabled LaserFect technology for low-toxicity delivery of siRNA into cells "that are typically refractory to standard transfection techniques."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.